---
layout: post
title: "Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments"
date: 2026-02-05 18:35:42 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-03808
original_published: 2023-02-24 00:00:00 +0000
significance: 8.00
---

# Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** February 24, 2023 00:00 UTC
**Document Number:** 2023-03808

## Summary

The United States Patent and Trademark Office (USPTO), Department of Commerce, in collaboration with the United States Food and Drug Administration (FDA), Department of Health and Human Services, is extending the written comment period for the notice titled "Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments" that was published in the Federal Register on November 7, 2022, until March 10, 2023.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/02/24/2023-03808/joint-uspto-fda-collaboration-initiatives-notice-of-public-listening-session-and-request-for)
- API: https://www.federalregister.gov/api/v1/documents/2023-03808

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
